Abstract:The progressive loss and degeneration of neurons in the central nervous system (CNS), as a result of traumas or diseases including Alzheimer’s, Parkinson’s, Huntington’s disease, stroke, and traumatic injury to the brain and spinal cord, can usually have devastating effects on quality of life. The current strategies available for treatments are described including drug delivery, surgery, electrical stimulation, and cell-based tissue engineering approaches. However, apart from cell-based therapy, other attempts are limited in improving clinical outcomes. Recently, stem cell and neural stem cell (NSC) in particular therapy has been proposed as an attractive and promising strategy for regenerative medicine due to their unique biological attributes, such as giving rise to neuronal lineage commitment in accordance with the neural development. Nevertheless, stem cell strategy still faces numerous challenges, including ethical issue, tumor formation, and graft rejection. Thus, seeking a more appropriate approach like direct reprogramming or lineage reprogramming is critical. Compared to induced pluripotent stem cells (iPSCs) and embryonic stem cells (ESCs), direct lineage reprogramming of somatic cells to generate induced neurons (iNs) without undergoing a state of pluripotent still has several advantages such as short induction cycle, high transdifferentiation efficiency, no ethical concerns, and risk of neoplasia. On the basis of these advantages, cell reprogramming will hold great promise for therapeutic cell replacement, disease modeling establishment, drug screening, and personalized medicine. Here, we systematically review recent advances in somatic lineage reprogramming into iNs, including the identification of novel reprogramming factors, the underlying molecular mechanisms and the concerns exist, as well as the major challenges in the future.

Direct reprogramming of Sertoli cells into multipotent neural stem cells by defined factors

Direct Reprogramming of Mouse Fibroblasts to Neural Progenitors

Direct Reprogramming of Fibroblasts into Neural Stem Cells by Single Non-Neural Progenitor Transcription Factor Ptf1a

Reprogrammed Astrocytes As a Potential Therapy for Neurodegenerative Disorders.

Induced Neural Stem/precursor Cells for Fundamental Studies and Potential Application in Neurodegenerative Diseases

Direct Conversion of Dermal Fibroblasts into Neural Progenitor Cells by a Novel Cocktail of Defined Factors.

Direct Reprogramming of Adult Human Fibroblasts to Functional Neurons under Defined Conditions.

Direct Conversion of Somatic Cells into Induced Neurons

Direct Reprogramming of Mouse Fibroblasts to Neural Stem Cells by Small Molecules

Induced pluripotency and direct reprogramming: a new window for treatment of neurodegenerative diseases

Direct Conversion of Cord Blood CD34+ Cells into Neural Stem Cells by OCT4

Reprogramming Fibroblasts to Neural Stem Cells by Overexpression of the Transcription Factor Ptf1a

Progress and Challenges of Cell Replacement Therapy for Neurodegenerative Diseases Based on Direct Neural Reprogramming

Generation of Patient-Specific Induced Neuronal Cells Using A Direct Reprogramming Strategy

Pharmacological Reprogramming of Fibroblasts into Neural Stem Cells by Signaling-Directed Transcriptional Activation

Reprogramming of Adult Human Neural Stem Cells into Induced Pluripotent Stem Cells

Reprogramming Sertoli Cells into Pluripotent Stem Cells

Characterization of Induced Neural Progenitors from Skin Fibroblasts by a Novel Combination of Defined Factors

Chemically Induced Reprogramming of Somatic Cells to Pluripotent Stem Cells and Neural Cells

Direct conversion of mouse astrocytes into neural progenitor cells and specific lineages of neurons

Small-Molecule-Driven Direct Reprogramming of Mouse Fibroblasts into Functional Neurons